Setterwalls advised Guard Therapeutics. Guard Therapeutics International AB announced a rights issue that was subscribed to approximately 214 per cent, and subsequent over allotment-issue to accommodate…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
